Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes

Y Kuwatsuka, K Miyamura, R Suzuki… - Blood, The Journal …, 2009 - ashpublications.org
We analyzed 338 adult patients with acute myeloid leukemia (AML) with t (8; 21) and inv
(16) undergoing stem cell transplantation (SCT) who were registered in the Japan Society …

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes

Y Kuwatsuka, K Miyamura, R Suzuki, M Kasai… - Blood, 2009 - cir.nii.ac.jp
抄録< jats: p> We analyzed 338 adult patients with acute myeloid leukemia (AML) with t (8;
21) and inv (16) undergoing stem cell transplantation (SCT) who were registered in the …

[引用][C] Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes

Y KUWATSUKA, K MIYAMURA, Y ATSUTA… - Blood, 2009 - pascal-francis.inist.fr
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia : t(8;21)
and inv(16) represent different clinical outcomes CNRS Inist Pascal-Francis CNRS Pascal …

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes.

Y Kuwatsuka, K Miyamura, R Suzuki, M Kasai… - Blood, 2009 - europepmc.org
We analyzed 338 adult patients with acute myeloid leukemia (AML) with t (8; 21) and inv
(16) undergoing stem cell transplantation (SCT) who were registered in the Japan Society …

[PDF][PDF] Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes

Y Kuwatsuka, K Miyamura, R Suzuki, M Kasai… - Blood, 2009 - academia.edu
We analyzed 338 adult patients with acute myeloid leukemia (AML) with t (8; 21) and inv
(16) undergoing stem cell transplantation (SCT) who were registered in the Japan Society …

[PDF][PDF] Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes

Y Kuwatsuka, K Miyamura, R Suzuki, M Kasai… - Blood, 2009 - researchgate.net
We analyzed 338 adult patients with acute myeloid leukemia (AML) with t (8; 21) and inv
(16) undergoing stem cell transplantation (SCT) who were registered in the Japan Society …

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes

Y Kuwatsuka, K Miyamura, R Suzuki, M Kasai… - …, 2009 - pubmed.ncbi.nlm.nih.gov
We analyzed 338 adult patients with acute myeloid leukemia (AML) with t (8; 21) and inv
(16) undergoing stem cell transplantation (SCT) who were registered in the Japan Society …

[HTML][HTML] Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes

Y Kuwatsuka, K Miyamura, R Suzuki, M Kasai… - Blood, 2009 - Elsevier
We analyzed 338 adult patients with acute myeloid leukemia (AML) with t (8; 21) and inv
(16) undergoing stem cell transplantation (SCT) who were registered in the Japan Society …

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: T (8; 21) and inv (16) represent different clinical outcomes

Y Kuwatsuka, K Miyamura, R Suzuki, M Kasai… - Blood, 2009 - keio.elsevierpure.com
抄録 We analyzed 338 adult patients with acute myeloid leukemia (AML) with t (8; 21) and
inv (16) undergoing stem cell transplantation (SCT) who were registered in the Japan …

[引用][C] Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes

Y KUWATSUKA - Blood, 2009 - cir.nii.ac.jp
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia : t(8;21)
and inv(16) represent different clinical outcomes | CiNii Research CiNii 国立情報学研究所 学術 …